Medicare Enrolled
Dr. Robert Guirguis, DO
Pain Medicine (Physical Medicine & Rehabilitation) Physician · Tampa, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Guirguis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Guirguis?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Guirguis
Dr. Robert Guirguis is a pain medicine physician in Tampa, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Guirguis performed 2,539 Medicare services across 1,169 unique beneficiaries.
Between the years covered by Open Payments, Dr. Guirguis received a total of $24,660 from 62 pharmaceutical and/or device companies across 935 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine (physical medicine & rehabilitation) physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Guirguis is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 34% volume in FL
$24,660 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,539
Medicare services
Top 34% in FL for pain medicine (physical medicine & rehabilitation) physician
1,169
Unique beneficiaries
$78
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~134 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
834 | $66 | $727 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
644 | $87 | $1,024 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
227 | $1 | $5 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
153 | $61 | $479 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
100 | $153 | $1,252 |
| Spinal drug pump reprogramming and refill A physician electronically adjusts the settings of a spinal drug infusion pump and refills its medication reservoir. |
76 | $64 | $752 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
55 | $72 | $366 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
54 | $110 | $1,351 |
| Spinal neurostimulator electrode insertion A procedure to place an electrode array into the spine through the skin. The electrode is used to deliver electrical stimulation to the nervous system. |
47 | $248 | $18,629 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
40 | $101 | $2,594 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
40 | $58 | $1,373 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
39 | $108 | $400 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
31 | $204 | $1,499 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
27 | $151 | $3,578 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
26 | $109 | $2,547 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
26 | $63 | $1,291 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
26 | $47 | $1,961 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
26 | $195 | $1,585 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
25 | $75 | $2,087 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
24 | $48 | $502 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
19 | $81 | $2,125 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$24,660
Total received (2018-2024)
Avg $3,523/year across 7 years
Top 7% in FL for pain medicine (physical medicine & rehabilitation) physician
62
Companies
935
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,639 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$21 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$7,740
2023
$5,483
2022
$3,922
2021
$1,900
2020
$1,545
2019
$3,251
2018
$820
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$4,788
Abbott Laboratories
$1,854
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,570
Boston Scientific Corporation
$1,569
Collegium Pharmaceutical, Inc.
$1,303
Curonix LLC
$1,266
Relievant Medsystems, Inc.
$1,205
ABBVIE INC.
$1,178
Nevro Corp.
$1,062
SCILEX PHARMACEUTICALS INC.
$689
PFIZER INC.
$685
IDORSIA PHARMACEUTICALS US INC
$581
Medtronic USA, Inc.
$556
Biohaven Pharmaceutical Holding Company Ltd.
$493
TerSera Therapeutics LLC
$475
Scilex Pharmaceuticals Inc.
$393
Eisai Inc.
$341
Stimwave Technologies Incorporated
$313
Azurity Pharmaceuticals, Inc.
$310
Allergan, Inc.
$273
RedHill Biopharma Inc.
$267
Electronic Waveform Lab, Inc.
$266
Biohaven Pharmaceuticals, Inc.
$258
Lilly USA, LLC
$206
AbbVie Inc.
$193
AstraZeneca Pharmaceuticals LP
$180
Zynex Medical, Inc.
$180
ARBOR PHARMACEUTICALS, INC.
$158
Novartis Pharmaceuticals Corporation
$133
SPR Therapeutics, Inc
$130
Amgen Inc.
$127
Teva Pharmaceuticals USA, Inc.
$127
E.R. Squibb & Sons, L.L.C.
$121
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$114
Forte Bio-Pharma LLC
$94
BioDelivery Sciences International, Inc.
$91
Daiichi Sankyo Inc.
$79
Kaleo, Inc.
$78
IBSA Pharma Inc.
$74
Allergan Inc.
$71
US WorldMeds, LLC
$68
Flowonix Medical Incorporated
$68
Nuvectra Corporation
$61
Takeda Pharmaceuticals U.S.A., Inc.
$58
Purdue Pharma L.P.
$53
PROTEGA PHARMACEUTIALS INC
$41
ASSERTIO THERAPEUTICS, Inc.
$40
Shionogi Inc
$39
Biogen, Inc.
$39
Horizon Therapeutics plc
$38
Nalu Medical, Inc.
$38
EISAI INC.
$37
GRT US Holding, Inc.
$34
Arbor Pharmaceuticals, Inc.
$33
CoreLink, LLC
$30
Vertos Medical, Inc.
$26
Hikma Pharmaceuticals USA
$21
Pacira Pharmaceuticals Incorporated
$21
USWM, LLC
$19
INSYS Therapeutics Inc
$19
FIDIA PHARMA USA INC.
$14
Avanir Pharmaceuticals, Inc.
$12
Top 3 companies account for 33.3% of total payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · ALSUMA · Aimovig · Algovita · Amitiza · BELBUCA · BOTOX · BUNAVAIL 2.1 mg 30-count box · Belbuca · COMIRNATY · Cambia · Dayvigo · EMBEDA · EMGALITY · ETERNA · EVZIO · Evzio · Exparel · GENERAL - VASCULAR INTERVENTION · HORIZANT · Horizant · Hymovis · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · Kloxxado · LICART · LUCEMYRA · LYRICA · Lucemyra · Lucemyra/Lofexidine · MOTEGRITY · MOVANTIK · Morphabond ER · Movantik · NALOCET · NURTEC ODT · Nalocet · Nalu Neurostimulation System · Nexwave · ONZETRA Xsail · PAXLOVID · PENNSAID · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PRIALT · PROCLAIM · Prialt · Proclaim DRG IPG · Proclaim Family of SCS IPGs · Proclaim IPG · Prodigy Family of SCS IPGs · Prometra II · QULIPTA · QUVIVIQ · Qutenza · RELISTOR · RELISTOR ORAL · REYVOW · ROXYBOND · SPINRAZA · SPRINT PNS System · SYMPROIC · SYNCHROMED · SYNDROS · Senza · Senza Spinal Cord Stimulation System · Symproic · Tirosint · UBRELVY · VANTA ADAPTIVESTIM · Vanta · WaveWriter Alpha Prime 16 · XTAMPZA · XTAMPZAER · Xtampza ER · ZEPOSIA · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for pain medicine (physical medicine & rehabilitation) physician in FL.
Equivalent to $971 per 100 Medicare services performed
Geographic Context
Pain medicine physicians within 10 mi
29
Per 100K population
1.9
County median income
$75,011
Nearest hospital
AdventHealth Carrollwood
2.9 mi
2.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Guirguis is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 7% of FL peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Guirguis experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Guirguis performed 834 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Guirguis receive payments from pharmaceutical companies?
Yes. Dr. Guirguis received a total of $24,660 from 62 companies across 935 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Guirguis's costs compare to other pain medicine physicians in Tampa?
Dr. Guirguis's average Medicare payment per service is $78. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Guirguis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicine Physicians in Tampa
Browse pain medicine physicians in Tampa ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicine Physicians in FL
Pain medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicine Physicians in FL
Which FL pain medicine physicians receive the most from drug and device companies.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology